JPMorgan to price contingent interest autocalls tied to Teladoc

By Sarah Lizee

Olympia, Wash., Aug. 13 – JPMorgan Chase Financial Co. LLC plans to price autocallable contingent interest notes due Feb. 17, 2023 linked to Teladoc Health, Inc. common stock, according to a 424B2 filing with the Securities and Exchange Commission.

The notes will pay a contingent quarterly coupon at an annual rate of 17.75% if the stock closes at or above its 50% coupon barrier on the review date for that quarter.

The notes will be called at par plus the contingent coupon if the stock closes at or above 90% of its initial level on any review date other than the final date.

The payout at maturity will be par plus the coupon unless the stock finishes below its 50% trigger level, in which case investors will lose 1% for every 1% that the stock declines.

The notes are guaranteed by JPMorgan Chase & Co.

J.P. Morgan Securities LLC is the agent.

The notes will price on Aug. 14.

The Cusip number is 48132M5L1.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.